Search company, investor...
Search

Predict your next investment

Venture Capital
hginitiative.com

See what CB Insights has to offer

Investments

19

Portfolio Exits

1

About HG Initiative

HG Initiative (HGI) is an impact-driven business designed to propagate a value-driven lifestyle. HGI is engaged in social investment and real estate development.

HG Initiative Headquarters Location

20, Seoulsup 6-gil, Seongdong-gu Sam-il Building 2F

Seoul, 04768,

South Korea

+82 02-461-9769

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest HG Initiative News

Veterinary Precision Medicine Company ImpriMed Raises $8 Million

Apr 19, 2021

ImpriMed — a leading veterinary precision medicine startup — announced recently that it has closed a total of $8 million in Pre-Series A funding. These are the details. ImpriMed — a leading veterinary precision medicine startup — announced recently that it has closed a total of $8 million in Pre-Series A funding with $7.7 million from VCs and the rest as government grant. This round of funding was led by HG Initiative and other participants include Draper Associates, Draper Dragon, BonAngels, Murex Partners, Translink Investment, Primer Sazze, FuturePlay, and ES Investor. What does ImpriMed do? ImpriMed utilizes AI to predict which anti-cancer drugs are most likely to be effective for a particular dog’s lymphoma or leukemia using live data generated from chemosensitivity and immunophenotyping assays on a patient’s fresh cancer cells. And its innovative approach to pet cancer care enables veterinary oncologists to make chemotherapy decisions with confidence, knowing quantified drug response predictions prior to actual drug administration. With this round of funding, ImpriMed plans to develop additional prediction models for their current target patients in canine blood cancers, scale up their customer network, and expand pipelines to other types of cancers in dogs and cats. ImpriMed has been able to clinically validate its patented technology with a peer-reviewed journal publication in Veterinary and Comparative Oncology that demonstrated an accurate prediction of tumor size reduction and a faster time to remission when using the ImpriMed Chemo Response Prediction service. And so far, more than 2,000 services have been provided to community treated canine patients. KEY QUOTES: “ImpriMed is breaking new ground in medicine. Using artificial intelligence to test drugs in pets can lead to solving many diseases in pets and the company could be an onramp for breakthroughs with humans. Enormous opportunity.”  — Tim Draper, Founding Partner at Draper Associates “HG Initiative along with other investors, is a welcome endorsement for ImpriMed’s AI-Driven Personalized Chemo Response Prediction tool and its viability. We look forward to all the benefits and access this funding will provide to support oncologists and pet parents to improve therapeutic options for their pets and will allow us to develop more finely tuned AI models to increase the accuracy of our service reports.”  — Dr. Sungwon Lim, CEO and Co-Founder at ImpriMed

HG Initiative Investments

19 Investments

HG Initiative has made 19 investments. Their latest investment was in Caring as part of their Series A on August 8, 2022.

CBI Logo

HG Initiative Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/31/2022

Series A

Caring

$22.38M

Yes

2

7/20/2022

Bridge

Netspa

$1.15M

Yes

1

3/16/2022

Seed VC

Baree

Yes

2

8/27/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

8/9/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/31/2022

7/20/2022

3/16/2022

8/27/2021

8/9/2021

Round

Series A

Bridge

Seed VC

Series A

Series A

Company

Caring

Netspa

Baree

Subscribe to see more

Subscribe to see more

Amount

$22.38M

$1.15M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

2

10

10

HG Initiative Portfolio Exits

1 Portfolio Exit

HG Initiative has 1 portfolio exit. Their latest portfolio exit was Radish on May 11, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/11/2021

Acquired

$99M

10

Date

5/11/2021

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Sources

10

HG Initiative Team

1 Team Member

HG Initiative has 1 team member, including current Chief Executive Officer, Kyungsun Chung.

Name

Work History

Title

Status

Kyungsun Chung

Chief Executive Officer

Current

Name

Kyungsun Chung

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.